CUHK Shenzhen Research Institute (SZRI) ACC-CUHK Joint Center
Introduction
Collaborative strategy has been signed by both CUHK past and current president (VC) and ACC director in 2007 and 2010. Based on previous CUHK-ACC successful completion of human bed-rest study for short-term space mission and to move to mid- and long-term space program, the CUHK Shenzhen Research Base for Health Maintenance of Musculoskeletal System has been established for further collaboration.
Explorative directions to Innovation and R & D cooperation
| • |
Anti weightlessness mechanics |
| • |
Development of local and systemic bone targeting system with phytomolecule icaritin delivery applied for osteogenic and anti-adipogenic effects |
| • |
Development of oral tablets with phytomolecule icaritin applied for osteogenic and anti-adipogenic effects |
| • |
Research on exoskeleton |
| |
|
Our Members
Our Projects
Activities
1. Preliminary results of cooperation of CUHK-ACC
| • |
The CUHK-Shenzhen research institute and international collaborators including the Centre national d'études spatiales (CNES) participated in the 1st 60-day head down bed rest (HDBR) clinical trial organized by the Chinese Astronaut Research and Training Center in China. |
| • |
Manuscripts on collaborative osteogenic research were published in top international journals. |
2. In November 19, 2012, we have organized the 2nd CUHK International Symposium on Stem Cells and Regenerative Medicine in CUSZRI, with more than 200 people attended the symposium, and this is the first international symposium has been ever organized in the newly established CUSZRI.
3. We have successfully held the First Space Medicine Forum in CUSZRI on 20 January 2013, with more than 50 people attended the meeting, including most of the PIs from ACC and CUHK, and invited speakers from other part of Shenzhen city.
4. We hosted ACC delegation led by vice director Dr. Bai YQ and SKL director
Dr. Li YH in March 2013. We signed memorandum for facilitating our ACC-CUHK joint center in CUSZRI after this visit. Following key issues have been addressed: 1) ACC would provide KSL seeding fund to our joint lab in SZ; 2) CUHK would explore matching fund; 3) CU would prepare for proposal for raising joint center donation and prepare for visit of CUHK president Prof. Sung in August 2013.
5. 15 August 2013, a delegation led by PVC Joseph Sung, Prof. Qin Ling and Prof. Li Gang has visited ACC, and both sides have agreed to consolidate the collaborations on extra-skeleton, digestive system in space, stem cells functions in space and human-machine interface. Agreement has been reached to put more resources from both sides to start the joint projects, and also look for potential major grant opportunities in China, Shenzhen as well as potential major donation from Hong Kong side. ACC has promised to release a funding of RMB 1 million to CUHK-ACC joint center in 3 years and Prof. Joseph Sung promised to match the funding and also to follow up the donation funding raising opportunities in Hong Kong.
 
6. October 2013, ACC has agreed to release 3 state key lab open projects to PIs associated with CUHK-ACC joint center with RMB 80,000 each. The first 3 projects recommended are: 1) Prof. Qin Ling, Mg+ implant; 2) Prof. LI Gang, MSCs Osteogenic differentiation under microgravity; 3) Prof. Li Gang and Prof. Jing XH (SBS), Embryonic stem cells neuronal differentiation potentials under microgravity conditions.
7. November 2013, CUHK as approved an additional HK$1.2 Million to match the funding from ACC, under the scheme of SMART, Institute of Innovative Medicine.
Shenzhen Institute of Advanced Technology (SIAT) Orthopaedic Research Laboratory of Translational Medicine Research and Development Center
The Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Science (CAS) comprise five institutes and numerous other labs and facilities. SIAT was jointly established by CAS, the Shenzhen municipal government and the Chinese University of Hong Kong in February 2006. SIAT aims to enhance the innovative capacity of the equipment manufacturing and service industries in the Guangdong-Hong Kong region, promote the development of emerging industries possessing their own proprietary intellectual property, and become a world-class industrial research institute.
SIAT’s main component divisions include the Shenzhen Institute of Advanced Integration Technology (SIIT), the Institute of Biomedical and Health Engineering (IBHE), the Institute of Advanced Computing and Digital Engineering (IACDE), the Institute of Biomedicine and Biotechnology (IBB) ,the Institute of Brain Cognition and Brain Disorders(IBCBD) and the Guangzhou Institute of Advanced Technology (GIAT), as well as the National Engineering Laboratory of Biomedical Informatics and Healthcare and the National Engineering Laboratory of High-density Integrated Circuit Packaging Technology. It is also home to five key labs and platforms at the provincial level and 18 key labs and platforms at the municipal level.
 http://english.siat.cas.cn/
|
